← All trials
NCT01048567
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2011
- Primary completion
- Oct 31, 2011
- Completion date
- Oct 31, 2011
- First posted
- Jan 13, 2010
- Last posted
- Dec 19, 2013
- Enrollment
- 7
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Vancouver Island Health AuthorityLead sponsor
- Canadian Society of Hospital PharmacistsCollaborator
- Vancouver Island Health AuthorityOverall official - principal investigator
- Vancouver Island Health AuthorityReponsible party - principal investigator
- Vancouver Island Health AuthoritySponsor investigator
- Vancouver Island Health AuthorityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.